Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Tsuda

Showing results (401-410 of 478) with videos related to

Pageof 48
Sort By:
Breast Cancer Research and Treatment|December 1, 2020
Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur-uracil with CMF (N·SAS-BC 01 trial and CUBC trial)Shinji Ohno, Shigehira Saji, Norikazu Masuda, et al.
Genome Research|July 16, 2014
Unique mutation portraits and frequent COL2A1 gene alteration in chondrosarcomaYasushi Totoki, Akihiko Yoshida, Fumie Hosoda, et al.
Molecular and Clinical Oncology|March 21, 2014
Extended trastuzumab therapy improves the survival of HER2-positive breast cancer patients following surgery and radiotherapy for brain metastasesYoshiko Okita, Yoshitaka Narita, Tsuyoshi Suzuki, et al.
ESMO Open|August 2, 2017
Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancerAtsuko Kitano, Makiko Ono, Masayuki Yoshida, et al.
Japanese Journal of Clinical Oncology|April 27, 2013
The prognostic value of pfetin: a validation study in gastrointestinal stromal tumors using a commercially available antibodyDaisuke Kubota, Kenta Mukaihara, Akihiko Yoshida, et al.
British Journal of Cancer|November 30, 2016
Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinomaTakuma Ohashi, Shuhei Komatsu, Daisuke Ichikawa, et al.
Plos One|August 27, 2013
Gene expression network analysis of ETV1 reveals KCTD10 as a novel prognostic biomarker in gastrointestinal stromal tumorDaisuke Kubota, Akihiko Yoshida, Hitoshi Tsuda, et al.
JMA Journal|February 10, 2025
Design Paper: A Prospective, Multicenter, Single-arm, Phase II Trial of Tailored Axillary Surgery in Patients with Clinically Node-positive Breast Cancer in the Upfront Surgery SettingYasuaki Sagara, Kaori Terata, Takehiko Sakai, et al.
Annals of Surgical Oncology|June 24, 2024
Development and Validation Study of the Prognostic Impact of Deep Learning-Determined Myxoid Stroma After Neoadjuvant Chemotherapy in Patients with Esophageal Squamous Cell CarcinomaKeita Kouzu, Hironori Tsujimoto, Yu Imamura, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 6, 2013
SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosisRie Ohtomo, Taisuke Mori, Shinsuke Shibata, et al.
Pageof 48

Showing results (401-410 of 478) with videos related to

Sort By:
Pageof 48
Breast Cancer Research and Treatment|December 1, 2020
Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur-uracil with CMF (N·SAS-BC 01 trial and CUBC trial)Shinji Ohno, Shigehira Saji, Norikazu Masuda, et al.
Genome Research|July 16, 2014
Unique mutation portraits and frequent COL2A1 gene alteration in chondrosarcomaYasushi Totoki, Akihiko Yoshida, Fumie Hosoda, et al.
Molecular and Clinical Oncology|March 21, 2014
Extended trastuzumab therapy improves the survival of HER2-positive breast cancer patients following surgery and radiotherapy for brain metastasesYoshiko Okita, Yoshitaka Narita, Tsuyoshi Suzuki, et al.
ESMO Open|August 2, 2017
Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancerAtsuko Kitano, Makiko Ono, Masayuki Yoshida, et al.
Japanese Journal of Clinical Oncology|April 27, 2013
The prognostic value of pfetin: a validation study in gastrointestinal stromal tumors using a commercially available antibodyDaisuke Kubota, Kenta Mukaihara, Akihiko Yoshida, et al.
British Journal of Cancer|November 30, 2016
Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinomaTakuma Ohashi, Shuhei Komatsu, Daisuke Ichikawa, et al.
Plos One|August 27, 2013
Gene expression network analysis of ETV1 reveals KCTD10 as a novel prognostic biomarker in gastrointestinal stromal tumorDaisuke Kubota, Akihiko Yoshida, Hitoshi Tsuda, et al.
JMA Journal|February 10, 2025
Design Paper: A Prospective, Multicenter, Single-arm, Phase II Trial of Tailored Axillary Surgery in Patients with Clinically Node-positive Breast Cancer in the Upfront Surgery SettingYasuaki Sagara, Kaori Terata, Takehiko Sakai, et al.
Annals of Surgical Oncology|June 24, 2024
Development and Validation Study of the Prognostic Impact of Deep Learning-Determined Myxoid Stroma After Neoadjuvant Chemotherapy in Patients with Esophageal Squamous Cell CarcinomaKeita Kouzu, Hironori Tsujimoto, Yu Imamura, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 6, 2013
SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosisRie Ohtomo, Taisuke Mori, Shinsuke Shibata, et al.
Pageof 48